5.54
Precedente Chiudi:
$5.44
Aprire:
$5.55
Volume 24 ore:
532.81K
Relative Volume:
0.66
Capitalizzazione di mercato:
$301.66M
Reddito:
$47.27M
Utile/perdita netta:
$6.46M
Rapporto P/E:
48.17
EPS:
0.115
Flusso di cassa netto:
$20.57M
1 W Prestazione:
+6.13%
1M Prestazione:
-29.43%
6M Prestazione:
+103.68%
1 anno Prestazione:
+19.65%
Paysign Inc Stock (PAYS) Company Profile
Nome
Paysign Inc
Settore
Industria
Telefono
702-453-2221
Indirizzo
2615 ST. ROSE PARKWAY, HENDERSON, NV
Confronta PAYS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PAYS
Paysign Inc
|
5.54 | 305.48M | 47.27M | 6.46M | 20.57M | 0.115 |
![]()
MSFT
Microsoft Corporation
|
520.58 | 3.88T | 281.72B | 101.83B | 71.61B | 13.64 |
![]()
ORCL
Oracle Corp
|
244.18 | 709.74B | 57.40B | 12.44B | -394.00M | 4.34 |
![]()
PLTR
Palantir Technologies Inc
|
184.33 | 433.38B | 3.44B | 763.29M | 1.71B | 0.30 |
![]()
CRWD
Crowdstrike Holdings Inc
|
432.12 | 106.29B | 4.14B | -172.30M | 1.03B | -0.69 |
![]()
SNPS
Synopsys Inc
|
618.57 | 114.01B | 6.22B | 2.16B | 1.09B | 13.85 |
Paysign Inc Stock (PAYS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-20 | Iniziato | Lake Street | Buy |
2022-03-30 | Iniziato | Barrington Research | Mkt Perform |
2022-03-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
2021-08-19 | Aggiornamento | DA Davidson | Neutral → Buy |
2021-08-12 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
2021-05-12 | Aggiornamento | Ladenburg Thalmann | Sell → Neutral |
2020-12-23 | Downgrade | Canaccord Genuity | Buy → Hold |
2020-11-18 | Downgrade | DA Davidson | Buy → Neutral |
2020-11-18 | Downgrade | Ladenburg Thalmann | Neutral → Sell |
2020-08-17 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
2020-04-07 | Reiterato | Maxim Group | Buy |
2019-11-15 | Iniziato | DA Davidson | Buy |
2019-08-06 | Aggiornamento | BTIG Research | Sell → Neutral |
2019-07-22 | Downgrade | BTIG Research | Neutral → Sell |
2019-07-02 | Iniziato | Canaccord Genuity | Buy |
2019-06-17 | Downgrade | BTIG Research | Buy → Neutral |
2019-05-16 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Paysign Inc Borsa (PAYS) Ultime notizie
PaySign's Financial Growth and Strategic Initiatives Earn Buy Rating - AInvest
PaySign, Inc. (NASDAQ:PAYS) Q2 2025 Earnings Call Transcript - MSN
Price Channel Expanding on Paysign Inc.’s ChartBuy Signal Based on Chart Analysis Confirmed - beatles.ru
Lake Street Capital Issues Positive Forecast for Paysign (NASDAQ:PAYS) Stock Price - MarketBeat
Paysign to Present at Oppenheimer Technology Conference - AInvest
Paysign (NASDAQ:PAYS) Issues Quarterly Earnings Results - MarketBeat
Paysign, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st
Earnings Miss: Paysign, Inc. Missed EPS By 43% And Analysts Are Revising Their Forecasts - Yahoo Finance
Paysign, Inc. (NASDAQ:PAYS) Insider Matthew Louis Lanford Sells 26,367 Shares - MarketBeat
Paysign (NASDAQ:PAYS) Issues FY 2025 Earnings Guidance - MarketBeat
Paysign, Inc. (NASDAQ:PAYS) CFO Sells $215,507.64 in Stock - MarketBeat
Insider Selling: Paysign, Inc. (NASDAQ:PAYS) Insider Sells 26,521 Shares of Stock - MarketBeat
Insider Selling: Paysign, Inc. (NASDAQ:PAYS) CEO Sells 62,158 Shares of Stock - MarketBeat
Insider Selling: Paysign, Inc. (NASDAQ:PAYS) EVP Sells 14,160 Shares of Stock - MarketBeat
Paysign's Strategic Position in the Evolving Patient Affordability and Fintech Landscape - AInvest
Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference - Business Wire
GSA Capital Partners LLP Has $576,000 Stock Holdings in Paysign, Inc. (NASDAQ:PAYS) - MarketBeat
What analysts say about Paysign Inc. stockHigh Yield Portfolio Ideas - thegnnews.com
Paysign Inc. Reports Record Revenue and Strategic Growth - The Globe and Mail
3 Strong Buy Tech Stocks to Watch: Ceragon Networks, Alight, and PaySign - AInvest
Despite shrinking by US$125m in the past week, Paysign (NASDAQ:PAYS) shareholders are still up 126% over 3 years - simplywall.st
With A 37% Price Drop For Paysign, Inc. (NASDAQ:PAYS) You'll Still Get What You Pay For - 富途牛牛
Paysign 2025 Q2 Earnings Net Income Surges 99.1% - AInvest
PaySign Inc Reports Record Revenue and Strategic Expansions Amid Plasma Challenges in Q2 2025 Earnings Call - AInvest
PaySign (PAYS) Analyst Rating Maintained, Price Target Raised to $10 by Lake Street - AInvest
Paysign raises 2025 revenue guidance to up to $78.5M while expanding patient affordability programs - MSN
Paysign Inc's (PAYS) Q2 2025 Earnings and Strategic Expansion into the Pharma Sector: A Catalyst for Long-Term Growth - AInvest
Paysign Inc's Strategic Shift to Patient Affordability in Pharma: How Innovative Financial Models Are Driving Sustainable Revenue Growth and Redefining Value Chains - AInvest
Paysign's Strategic Shift in Patient Affordability and Financial Models in 2025: How B2B Payment Solutions Are Reshaping the Pharma Supply Chain - AInvest
The Resilient Business Model of Paysign: How Patient Affordability Programs Are Driving 2025 Revenue Growth to $78.5M - AInvest
PaySign Inc (PAYS) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Expansions ... - Yahoo Finance
PaySign Inc (PAYS) Q2 2025 Earnings Call Highlights: Record Reve - GuruFocus
Paysign price target raised to $10 from $9 at Lake Street - TipRanks
Paysign's Revenue Surge and Strategic Shifts in Patient Affordability: How Innovative Financial Models Are Reshaping Pharma's Value Chain in 2025 - AInvest
Paysign (PAYS) Q2 Revenue Jumps 33% - The Motley Fool
Paysign (PAYS) Q2 Revenue Jumps 33% - The Globe and Mail
Paysign, Inc. SEC 10-Q Report - TradingView
Paysign's Surging Revenue and Strategic Patient Affordability Expansion: Redefining Pharma Tech for a High-Growth Future - AInvest
Paysign Q2 2025 Earnings Call Transcript - MarketBeat
Paysign Raises 2025 Revenue Guidance to $78.5M, Expands Patient Affordability Programs - AInvest
Paysign, Inc. Reports Strong Q2 2025 Growth - TipRanks
Paysign Reports Record Q2 2025 Revenue, Doubles Net Income, and Receives Bullish Analyst Predictions - AInvest
Paysign's Q2 2025 Earnings and Strategic Transformation in Healthcare Payments: A Buy Before the Next Growth Cycle - AInvest
Paysign's Strategic Surge: A Catalyst for Healthcare Fintech's Future - AInvest
PaySign CEO Mark Newcomer Sells $440K Worth of Shares - AInvest
Earnings call transcript: Paysign Q2 2025 revenue beats forecast, EPS misses - Investing.com Nigeria
Paysign’s Pharma Bet Pays Off While Plasma Lags Behind - Finimize
Paysign Q2 revenue up 33%, beats analyst estimates - MarketScreener
Paysign Inc Azioni (PAYS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Paysign Inc Azioni (PAYS) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Newcomer Mark | CEO |
Aug 04 '25 |
Sale |
7.09 |
62,158 |
440,396 |
8,750,728 |
Strobo Robert | Chief Legal Officer |
Jul 31 '25 |
Option Exercise |
0.00 |
64,000 |
0 |
273,811 |
Strobo Robert | Chief Legal Officer |
Aug 04 '25 |
Sale |
7.09 |
26,521 |
187,904 |
247,290 |
Herman Joan M | EVP, Operations |
Jul 31 '25 |
Option Exercise |
0.00 |
36,000 |
0 |
835,743 |
Herman Joan M | EVP, Operations |
Aug 04 '25 |
Sale |
7.09 |
14,160 |
100,325 |
821,583 |
Baker Jeffery Bradford | Chief Financial Officer |
Jul 31 '25 |
Option Exercise |
0.00 |
64,000 |
0 |
282,669 |
Baker Jeffery Bradford | Chief Financial Officer |
Aug 04 '25 |
Sale |
7.09 |
30,396 |
215,359 |
252,273 |
Lanford Matthew Louis | Chief Payments Officer |
Jul 31 '25 |
Option Exercise |
0.00 |
64,000 |
0 |
173,731 |
Lanford Matthew Louis | Chief Payments Officer |
Aug 04 '25 |
Sale |
7.09 |
26,367 |
186,813 |
147,364 |
HENRY DANIEL R | Director |
Jun 16 '25 |
Buy |
4.96 |
10,084 |
50,000 |
129,884 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):